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Background: Prior studies have demonstrated higher mortality rates among women with STEMI even after adjustment for age and comorbidities. 
It has also been shown that women with STEMI tend to undergo less aggressive in hospital management. Our aim was to determine whether female 
gender is an independent predictor of in-hospital mortality, whether it influences the choice of reperfusion strategy and whether it influences the 
outcome of thrombolysis (TL) vs Primary PCI (PPCI).
Methods: The Belgian STEMI registry is a prospective registry (2007-2009) from unselected STEMI patients in 82 hospitals.
Results: 5672 (25.3% F and 74.7% M) patients were included. Women were older (69 vs 61y, p<0.001) had more hypertenion (HT) (57% vs 
41%, p<0.001),diabetes(DM) (20 vs 14%, p<0.001) and more frequently a body weight < 67 kg (44 vs 10%, p<0.001). They had less previous 
coronary artery disease (CAD) (16 vs 20%, p=0.02). They had a higher Killip Class (KC) (Killip>I:29.9% vs 21.7%, p<0,001) and TIMI risk score at 
admission (median 5 [3.0-7.0] vs 3 [2.0-5.0]). Women had more often an ischemic time>4h (50% vs 38%%, p<0.001). Women had a higher in-
hospital mortality compared to men (11 vs 6%, p<0.001). After adjustment in a logistic regression model including age, HT, DM, CAD, KC, weight<67, 
ischemic time<4h, CPR, infarct site, BP<100mmHg and HR>100/min significant sex differences in in-hospital mortality rates were no longer 
observed (p<0.19, Odds ratio=0.82; 95% CI 0.61-1.1). There were also no sex-differences in choice of reperfusion therapy. There are no differences 
in adjusted mortality between men and women in the thrombolysis (p=0.743, OR= 1.16; 95% CI =0.48-2.81) or PPCI group (p=0.058, OR 1.4; 95% 
CI=0.99-2).
Conclusions: Belgian women with STEMI are older, have more comorbidities and are more severely ill than their male counterparts. They have 
higher crude in-hospital mortality rates. In contrast to other non-Belgian registries sex differences in in-hospital mortality and reperfusion strategies 
in STEMI do not remain significant after multivariate adjustment. PPCI in Belgian women is not associated with a higher mortality and should be 
advocated in this high risk population.
